Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2003000272 - MEDICAMENTS CONTENANT DES DERIVES DE TETRAHYDROQUINOLEINE

Numéro de publication WO/2003/000272
Date de publication 03.01.2003
N° de la demande internationale PCT/EP2002/006905
Date du dépôt international 21.06.2002
Demande présentée en vertu du Chapitre 2 15.01.2003
CIB
A61K 31/435 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
33Composés hétérocycliques
395ayant l'azote comme hétéro-atome d'un cycle, p.ex. guanéthidine ou rifamycines
435ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle
A61K 31/706 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
70Hydrates de carbone; Sucres; Leurs dérivés
7042Composés ayant des radicaux saccharide et des hétérocycles
7052ayant l'azote comme hétéro-atome d'un cycle, p.ex. nucléosides, nucléotides 
706contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
CPC
A61K 31/435
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/706
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706containing six-membered rings with nitrogen as a ring hetero atom
Y02A 50/387
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
381the vector-borne disease being caused by a virus
384of the genus Flavivirus
387the disease being Yellow fever, i.e. Ochropyra
Y02A 50/409
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
408the vector-borne disease being caused by a protozoa
409of the genus Leishmania i.e. Leishmaniasis, Sand-fly fever, phlebotomus fever, kala-azar, black fever or Dumdum fever
Y02A 50/411
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
408the vector-borne disease being caused by a protozoa
411of the genus Plasmodium, i.e. Malaria
Y02A 50/414
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
38Medical treatment of vector-borne diseases characterised by the agent
408the vector-borne disease being caused by a protozoa
413of the genus Trypanosoma
414the protozoa being Trypanosoma cruzi i.e. Chagas disease or American trypanosomiasis
Déposants
  • INSTITUT FUER PFLANZENBIOCHEMIE-IPB [DE/DE]; Weinberg 3 06120 Halle (Saale), DE (AllExceptUS)
  • BUSKE, Alexander [DE/DE]; DE (UsOnly)
  • KEKULE, Alexander, S. [DE/DE]; DE (UsOnly)
  • HÄRING, Anke [DE/DE]; DE (UsOnly)
  • ADAM, Günter [DE/DE]; DE (UsOnly)
Inventeurs
  • BUSKE, Alexander; DE
  • KEKULE, Alexander, S.; DE
  • HÄRING, Anke; DE
  • ADAM, Günter; DE
Mandataires
  • GRÜNECKER, KINKELDEY, STOCKMAIR & SCHWANHÄUSSER ANWALTSSOZIETÄT; Maximilianstrasse 58 80538 München, DE
Données relatives à la priorité
101 29 927.321.06.2001DE
Langue de publication allemand (DE)
Langue de dépôt allemand (DE)
États désignés
Titre
(DE) ARZNEIMITTEL, ENTHALTEND DERIVATE VON TETRAHYDROCHINOLIN
(EN) MEDICAMENTS CONTAINING TETRAHYDROISOQUINOLINE DERIVATIVES
(FR) MEDICAMENTS CONTENANT DES DERIVES DE TETRAHYDROQUINOLEINE
Abrégé
(DE)
Die Erfindung betrifft Arzneimittel, enthaltend Derivate von Tetrahydrochinolin sowie deren Verwendung zur Behandlung von Tropenkrankheiten, insbesondere von Leishmaniosen, der Trypanosomiasis oder der Chagas-Krankheit.
(EN)
The invention relates to medicaments containing tetrahydroisoquinoline derivatives, in addition to the use thereof for treating tropical diseases, especially leishmanioses, trypanosomiasis or chagas disease.
(FR)
L'invention concerne des médicaments contenant des dérivés de tétrahydroquinoléine, ainsi que leur utilisation pour le traitement de maladies tropicales, notamment des leishmanioses, des trypanosomiases ou de la maladie de Chagas.
Également publié en tant que
Dernières données bibliographiques dont dispose le Bureau international